Groundbreaking research demands a new brand of CRO
Your regenerative medicine study requires an innovative partner—a CRO that understands the market’s intricacies and has the experience to guide your trial to success.
Biorasi is one of the few CROs that understands the regulatory, clinical, and logistical challenges of this specialized field. Our global presence means we know when to open sites internationally to improve patient recruitment. With our combination of clinical, project management, and data science experience, we’ll keep your trial moving forward.
Pursue Regenerative Medicine Therapies with Less Risk
When you need product transported to sites around the world, you want a CRO with the partners and experience to make it happen—on time, without error. Even better, Biorasi consistently shortens timelines by 70% on average over the course of a trial compared to industry standards.
Regenerative Medicine Hits a Turning Point
Technological advancements and regulatory support have given the regenerative medicine development new momentum. Soon, we may have viable stem cell treatments to slow down or stop the progression of Alzheimer’s and Parkinson’s disease and therapies that give people with spinal cord injuries newfound mobility.